Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06530186 · ClinicalTrials.gov registry record · NA
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
A NA study, sponsored by Atlantic Health System.
- Not yet
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT06530186: Clinical Trial NA study, sponsored by Atlantic Health System.
NCT06530186 is a NA study that has not yet begun recruiting, run by Atlantic Health System. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06530186, a NA study, has not yet begun recruiting, sponsored by Atlantic Health System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.
Interventions
- DEVICE LiviWell Postcoital Vaginal Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What is known before NCT06530186 opens enrollment
NCT06530186 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 1 intervention - of which LiviWell Postcoital Vaginal Insert is the first listed.
NCT06530186 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06530186 about?
NCT06530186 is a clinical study titled "Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters". LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Li...
What is the current status of trial NCT06530186?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-08-01. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT06530186?
The interventions under investigation include: LiviWell Postcoital Vaginal Insert (DEVICE).
Who is sponsoring clinical trial NCT06530186?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06530186's enrollment target sits among peer trials
1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI